Immunomodulatory effects of azithromycin revisited: potential applications to COVID-19

VJ Venditto, D Haydar, A Abdel-Latif… - Frontiers in …, 2021 - frontiersin.org
The rapid advancement of the COVID-19 pandemic has prompted an accelerated pursuit to
identify effective therapeutics. Stages of the disease course have been defined by viral …

Severe COVID-19 recovery is associated with timely acquisition of a myeloid cell immune-regulatory phenotype

AC Trombetta, GB Farias, AMC Gomes… - Frontiers in …, 2021 - frontiersin.org
After more than one year since the COVID-19 outbreak, patients with severe disease still
constitute the bottleneck of the pandemic management. Aberrant inflammatory responses …

The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study

N Ziadé, I Hmamouchi, L El Kibbi, N Abdulateef… - Clinical …, 2020 - Springer
Objective To evaluate the impact of the coronavirus disease 2019 (COVID-19) pandemic on
rheumatology practice. Method A cross-sectional web survey was designed by the members …

The role of antirheumatics in patients with COVID-19

CB Nissen, S Sciascia, D de Andrade… - The Lancet …, 2021 - thelancet.com
The COVID-19 pandemic has resulted in more than 2 million deaths globally. Two
interconnected stages of disease are generally recognised; an initial viral stage and a …

Management of childhood-onset autoinflammatory diseases during the COVID-19 pandemic

F Haslak, M Yildiz, A Adrovic, S Sahin, O Koker… - Rheumatology …, 2020 - Springer
Concerns regarding the comorbidity as a significant risk factor for Coronavirus Disease-
2019 (COVID-19), gave rise to an urgent need for studies evaluating patients with chronic …

Management of rheumatic diseases in the time of covid-19 pandemic: perspectives of rheumatology practitioners from India

L Gupta, DP Misra, V Agarwal, S Balan… - Annals of the rheumatic …, 2021 - ard.bmj.com
Of 861 invitees, 221 (25.7%; 92.7% adult rheumatologists, 52.2% academicians) responded.
Most perceived the need for a change in the management of RDs (online supplementar y …

[HTML][HTML] COVID-19: etiology, clinical picture, treatment

MY Shchelkanov, LV Kolobukhina… - Russian Journal of …, 2020 - iimmun.ru
Whereas the XX century marked the history of acute respiratory disease investigation as a
period for generating in-depth system of combating influenza viruses (Articulavirales …

Coronavirus disease 2019 (COVID-19) in a patient with ankylosing spondylitis treated with secukinumab: a case-based review

I Coskun Benlidayi, B Kurtaran, E Tirasci… - Rheumatology …, 2020 - Springer
Severe acute respiratory syndrome coranovirus-2 (SARS-CoV-2) infection has become an
important health-care issue worldwide. The coronavirus disease 2019 (COVID-19) has also …

Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial …

P Ruscitti, F Bruno, O Berardicurti, C Acanfora… - Annals of the …, 2020 - ard.bmj.com
Objectives To evaluate the clinical pictures, laboratory tests and imaging of patients with
lung involvement, either from severe COVID-19 or macrophage activation syndrome (MAS) …

[HTML][HTML] Childhood rheumatic diseases and COVID-19 pandemic: an intriguing linkage and a new horizon

F Haşlak, M Yıldız, A Adrovic, K Barut… - Balkan medical …, 2020 - ncbi.nlm.nih.gov
As it is known, we are all in a pandemic situation due to a novel coronavirus, officially named
“Severe Acute Respiratory Syndrome Coronavirus 2” and the disease caused by the virus …